Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc. > Summary
Court Case Number 1:17-cv-00393
Filing Date Apr 7, 2017
Termination Date Feb 26, 2018
Court Delaware District Court
Status Dismissed - Settled
Appeal2017-2176
JudgesRichard G. Andrews
Plaintiff
Defendant
Plaintiff Attorneys
4Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Benjamin A. Smyth
McCarter & English
Novartis
Attorney Name: Charlotte C. Jacobsen
Venable
Defendant Attorneys
6Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Ira J. Levy
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Todd Marabella
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Frederick H. Rein
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Calvin E. Wingfield
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Aviv Zalcenstein
Goodwin Procter LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09006224 | Neuroendocrine tumor treatment | Apr 14, 2015 |
| 08778962 | Treatment of solid tumors with rapamycin derivatives | Jul 15, 2014 |
| 08436010 | Treatment of solid tumors with rapamycin derivatives | May 7, 2013 |
| 08410131 | Cancer treatment | Apr 2, 2013 |
